Cancer Treatment and Research Communications | 卷:27 |
Non-rodent animal models of osteosarcoma: A review | |
Nikolaos Madouros1  Amber Saleem1  Evgenia Koumadoraki2  Shayka Sharif3  Safeera Khan3  Sommer Jarvis4  | |
[1] Behavioral Psychology, 4751 Mangels Blvd, Fairfield, CA 94534, United States; | |
[2] California Institute of Neurosciences & | |
[3] Corresponding author. 1600 Culver Drive Unit 72, N5V 3H5, London ON, Canada.; | |
关键词: Osteosarcoma; Pre-clinical research; Cam assay; Pig; Canine; | |
DOI : | |
来源: DOAJ |
【 摘 要 】
Osteosarcoma is extremely malignant, and the most common cancer that affects bone. Current treatments involve surgical resection of the affected area and multi-agent chemotherapy, though survival rate is generally poor for those affected by metastases. As treatment for osteosarcoma has remained unchanged for the past few decades, there is a need for further advancements in the understanding of osteosarcoma biology and therapeutics. Thus, reliable animal models that can accurately recapitulate the disease are required. Though rodents represent the most popular animal model of osteosarcoma, they may not model the disease best. This review analyzes emerging alternative non-rodent animal models of osteosarcoma, such as the chick chorioallantoic membrane (CAM) assay, pigs, and canines. Each of these alternatives offer advantages over classic rodent models for pre-clinical research. Research of these cross-species platforms imparts knowledge of metastases biology and potential new treatments for osteosarcoma.
【 授权许可】
Unknown